Clinical trial
Cryoablation Combined With Camrelizumab and Apatinib
NCT04724226 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cryoablation Combined With Camrelizumab and Apatinib
- Lead sponsor
- Sun Yat-sen University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 1, 2021
- Completion date
- August 31, 2024
- Enrollment
- 34 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma